EUVIMEDEUVIMED entdecken
Crossref

Chemical Novelty without Therapeutic Advantage: A Theoretical Account of How Generative Artificial Intelligence Should Reconcile Molecular Originality, Synthetic Accessibility, Selectivity, and Developability in Medicinal Chemistry

James Whitfield, Aisha Rahman, Kenji Sato, Sofia Lindqvist

Pharmacophore · 2026 · 17 (5) · 1-8

DOI: 10.51847/z45gbppbcs ↗

Kurz gefasst

Fachartikel in der Zeitschrift Pharmacophore, 2026. Verfasst von James Whitfield und 3 weiteren Autor:innen. Die Arbeit nennt 26 Literaturangaben.

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Kein Abstract verfügbar.

Zitieren

APA

Whitfield, J., Rahman, A., Sato, K., & Lindqvist, S. (2026). Chemical Novelty without Therapeutic Advantage: A Theoretical Account of How Generative Artificial Intelligence Should Reconcile Molecular Originality, Synthetic Accessibility, Selectivity, and Developability in Medicinal Chemistry. Pharmacophore, 17(5), 1-8. https://doi.org/10.51847/z45gbppbcs

Vancouver

Whitfield J, Rahman A, Sato K, Lindqvist S. Chemical Novelty without Therapeutic Advantage: A Theoretical Account of How Generative Artificial Intelligence Should Reconcile Molecular Originality, Synthetic Accessibility, Selectivity, and Developability in Medicinal Chemistry. Pharmacophore. 2026;17(5):1-8. doi:10.51847/z45gbppbcs

BibTeX
@article{Whitfield2026,
  author = {Whitfield, James and Rahman, Aisha and Sato, Kenji and Lindqvist, Sofia},
  title = {Chemical Novelty without Therapeutic Advantage: A Theoretical Account of How Generative Artificial Intelligence Should Reconcile Molecular Originality, Synthetic Accessibility, Selectivity, and Developability in Medicinal Chemistry},
  journal = {Pharmacophore},
  year = {2026},
  volume = {17},
  number = {5},
  pages = {1--8},
  doi = {10.51847/z45gbppbcs}
}
Kostenlos starten →